International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trialsT. Christopher Mast, John W. Shiver, Esper G. Kallás et al.|Vaccine|2009Cited by 276
Structural Analysis of the Unmutated Ancestor of the HIV-1 Envelope V2 Region Antibody CH58 Isolated From an RV144 HIV-1 Vaccine Efficacy Trial Vaccinee and Associated with Decreased Transmission RiskNathan I. Nicely, Barton F. Haynes, Kevin Wiehe et al.|Unknown|2014Cited by 0